鼻咽頭炎は、風邪とも呼ばれ、のどや鼻腔を侵す感染症で、炎症を起こす疾患です。風邪をひいた人が咳をしたり、くしゃみをしたり、話をしたりすると、空気中の飛沫によってウイルスが広がります。症状は、のどの痛み、鼻水、くしゃみ、倦怠感、頭痛、食欲不振などです。危険因子としては、年齢や免疫力の低下などが挙げられます。治療には、鎮痛薬と充血除去薬が使用されます。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Nasopharyngitis (Common Cold) - Overview
Nasopharyngitis (Common Cold) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Nasopharyngitis (Common Cold) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Nasopharyngitis (Common Cold) - Companies Involved in Therapeutics Development
Adare Pharma Solutions
Charleston Laboratories Inc
Eurofarma Laboratorios SA
Firebrick Pharma Pty Ltd
Pfizer Inc
SaNOtize Research and Development Corp
SSP Co Ltd
Tris Pharma Inc
Nasopharyngitis (Common Cold) - Drug Profiles
(acetaminophen + fexofenadine + phenylephrine) - Drug Profile
Product Description
Mechanism Of Action
guaifenesin ER - Drug Profile
Product Description
Mechanism Of Action
History of Events
hydrocodone bitartrate + Undisclosed drug - Drug Profile
Product Description
Mechanism Of Action
IMP-1088 - Drug Profile
Product Description
Mechanism Of Action
NORS-1002 - Drug Profile
Product Description
Mechanism Of Action
ORB-110 - Drug Profile
Product Description
Mechanism Of Action
History of Events
povidone iodine - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecule to Inhibit MAPK13 for Asthma and Cold - Drug Profile
Product Description
Mechanism Of Action
ST-HT - Drug Profile
Product Description
Mechanism Of Action
History of Events
TRN-123 - Drug Profile
Product Description
Mechanism Of Action
History of Events
TRN-124 - Drug Profile
Product Description
Mechanism Of Action
History of Events
TRN-125 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Nasopharyngitis (Common Cold) - Dormant Projects
Nasopharyngitis (Common Cold) - Discontinued Products
Nasopharyngitis (Common Cold) - Product Development Milestones
Featured News & Press Releases
Jul 01, 2015: Spriaso Announces Approval of New Drug Application for the Long Acting Codeine Antitussive With a Popular Anti-Histamine
Oct 10, 2013: Spriaso completes FDA Meeting on Tuxarin ER
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Nasopharyngitis (Common Cold), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Nasopharyngitis (Common Cold) - Pipeline by Adare Pharma Solutions, 2022
Nasopharyngitis (Common Cold) - Pipeline by Charleston Laboratories Inc, 2022
Nasopharyngitis (Common Cold) - Pipeline by Eurofarma Laboratorios SA, 2022
Nasopharyngitis (Common Cold) - Pipeline by Firebrick Pharma Pty Ltd, 2022
Nasopharyngitis (Common Cold) - Pipeline by Pfizer Inc, 2022
Nasopharyngitis (Common Cold) - Pipeline by SaNOtize Research and Development Corp, 2022
Nasopharyngitis (Common Cold) - Pipeline by SSP Co Ltd, 2022
Nasopharyngitis (Common Cold) - Pipeline by Tris Pharma Inc, 2022
Nasopharyngitis (Common Cold) - Dormant Projects, 2022
Nasopharyngitis (Common Cold) - Discontinued Products, 2022
List of Figures
Number of Products under Development for Nasopharyngitis (Common Cold), 2022
Number of Products under Development by Companies, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Stage and Molecule Types, 2022
